Publication: HIV vaccine research in Thailand: Lessons learned
Issued Date
2008-04-01
Resource Type
ISSN
17448395
14760584
14760584
Other identifier(s)
2-s2.0-42049092979
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Expert Review of Vaccines. Vol.7, No.3 (2008), 311-317
Suggested Citation
Punnee Pitisuttithum HIV vaccine research in Thailand: Lessons learned. Expert Review of Vaccines. Vol.7, No.3 (2008), 311-317. doi:10.1586/14760584.7.3.311 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/19340
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
HIV vaccine research in Thailand: Lessons learned
Author(s)
Other Contributor(s)
Abstract
Thailand is the only country that has conducted two Phase III efficacy trials and ten other Phase I/II studies using various HIV-1 vaccine constructs. This outstanding record is the result of strong efforts and commitment among various partners, including policy makers, regulators, researchers and foreign collaborators. Recently, it has become apparent that hardly any new HIV/AIDS candidate vaccines are in the pipeline reaching the stage of clinical testing, especially a candidate vaccine that is suitable for Thailand and the surrounding region. However, many lessons learned can be utilized or modified for other vaccine trials, particularly vaccines against other infectious diseases prevalent in developing countries. © 2008 Future Drugs Ltd.